Literature DB >> 14609567

Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects.

Kevin A O'Connor1, Michael K Hansen, C Rachal Pugh, Molly M Deak, Joseph C Biedenkapp, Erin D Milligan, John D Johnson, Haichao Wang, Steven F Maier, Kevin J Tracey, Linda R Watkins.   

Abstract

High mobility group box 1 (HMGB1), an abundant, highly conserved cellular protein, is widely known as a nuclear DNA-binding protein. HMGB1 has been recently implicated as a proinflammatory cytokine because of its role as a late mediator of endotoxin lethality and ability to stimulate release of proinflammatory cytokines from monocytes. Production of central cytokines is a critical step in the pathway by which endotoxin and peripheral proinflammatory cytokines, including interleukin-1beta (IL-1) and tumor necrosis factor-alpha (TNF), produce sickness behaviors and fever. Intracerebroventricular (ICV) administration of HMGB1 has been shown to increase TNF expression in mouse brain and induce aphagia and taste aversion. Here we show that ICV injections of HMGB1 induce fever and hypothalamic IL-1 in rats. Furthermore, we show that intrathecal administration of HMGB1 produces mechanical allodynia (lowering of the response threshold to calibrated stimuli). Finally, while endotoxin (lipopolysaccharide, LPS) administration elevates IL-1 and TNF mRNA in various brain regions, HMGB1 mRNA is unchanged. It remains possible that HMGB1 protein is released in brain in response to LPS. Nonetheless, these data suggest that HMGB1 may play a role as an endogenous pyrogen and support the concept that HMGB1 has proinflammatory characteristics within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609567     DOI: 10.1016/j.cyto.2003.08.001

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  47 in total

1.  Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Annemarie Ledeboer; Julie Wieseler-Frank; Erin D Milligan; Steven F Maier
Journal:  Brain Behav Immun       Date:  2006-12-18       Impact factor: 7.217

Review 2.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

3.  Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis.

Authors:  Hidehiro Sawa; Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Makoto Shinzeki; Takahiro Nakajima; Yoshikazu Kuroda
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

4.  Peripheral administration of fetuin-A attenuates early cerebral ischemic injury in rats.

Authors:  Haichao Wang; Wei Li; Shu Zhu; Jianhua Li; Jason D'Amore; Mary F Ward; Huan Yang; Rongqian Wu; Willi Jahnen-Dechent; Kevin J Tracey; Ping Wang; Andrew E Sama
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-02       Impact factor: 6.200

5.  High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia.

Authors:  Jianhua Qiu; Jian Xu; Yi Zheng; Ying Wei; Xiaoxia Zhu; Eng H Lo; Michael A Moskowitz; John R Sims
Journal:  Stroke       Date:  2010-07-29       Impact factor: 7.914

Review 6.  Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal.

Authors:  Michael D Weber; Jonathan P Godbout; John F Sheridan
Journal:  Neuropsychopharmacology       Date:  2016-06-20       Impact factor: 7.853

7.  Association of single-nucleotide polymorphisms of high-mobility group box 1 with susceptibility and clinicopathological characteristics of uterine cervical neoplasia in Taiwanese women.

Authors:  Hsin-Hung Wu; Yu-Fan Liu; Shun-Fa Yang; Wea-Lung Lin; Shiuan-Chih Chen; Chih-Ping Han; Hsiang-Ling Wang; Long-Yau Lin; Po-Hui Wang
Journal:  Tumour Biol       Date:  2016-10-04

8.  Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibit a Late Mediator of Lethal Sepsis, HMGB1.

Authors:  Shu Zhu; Wei Li; Jianhua Li; Andrew E Sama; Haichao Wang
Journal:  Int J Clin Exp Med       Date:  2008-01-20

Review 9.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

10.  Melatonin Ameliorates Lipopolysaccharide-Induced Microglial Inflammation via Triggering SIRT1/HMGB1 Signaling Axis.

Authors:  Enkhmurun Chibaatar; Kai Le; Idriss Ali Abdoulaye; Shanshan Wu; Yijing Guo
Journal:  J Mol Neurosci       Date:  2020-09-10       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.